Irritable Bowel Syndrome (IBS)

Global and China Irritable Bowel Syndrome (IBS) Market Research by Company, Type & Application 2013-2025

Report ID: HeyReport 33259 | Number of pages: 76 | Publish Date: Aug 2019 | Category: Lifesciences and Healthcare
Summary
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Market Segment as follows:
By Type
    IBS-D Drug
    IBS-C Drug
    Others
By Application
    Women
    Men
By Company
    Valeant Pharmaceuticals
    Allergan
    Takeda
    Sucampo Pharmaceuticals
    McNeil Consumer Healthcare
    Sebela Pharmaceuticals
    Astellas Pharmaceuticals
    IM HealthScience
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
    1.1 Market Segment Overview
        1.1.1 Product Definition
        1.1.2 Market by Type
            1.1.2.1 IBS-D Drug
            1.1.2.2 IBS-C Drug
            1.1.2.3 Others
        1.1.3 Market by Application
            1.1.3.1 Women
            1.1.3.2 Men
    1.2 Global and China Market Size
        1.2.1 Global Overview
        1.2.2 China Overview
2 Global and China Market by Company
    2.1 Global
        2.1.1 Global Sales by Company
        2.1.2 Global Price by Company
    2.2 China
        2.2.1 China Sales by Company
        2.2.2 China Price by Company
3 Global and China Market by Type
    3.1 Global
        3.1.1 Global Sales by Type
        3.1.2 Global Price by Type
    3.2 China
        3.2.1 China Sales by Type
        3.2.2 China Price by Type
4 Global and China Market by Application
    4.1 Global
        4.1.1 Global Sales by Application
        4.1.2 Global Price by Application
    4.2 China
        4.2.1 China Sales by Application
        4.2.2 China Price by Application
5 China Trade
    5.1 Export
    5.2 Import
6 Key Manufacturers
    6.1 Valeant Pharmaceuticals
        6.1.1 Company Information
        6.1.2 Product Specifications
        6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    6.2 Allergan
    6.3 Takeda
    6.4 Sucampo Pharmaceuticals
    6.5 McNeil Consumer Healthcare
    6.6 Sebela Pharmaceuticals
    6.7 Astellas Pharmaceuticals
    6.8 IM HealthScience
7 Industry Upstream
    7.1 Industry Chain
    7.2 Raw Materials
8 Market Environment
    8.1 SWOT
    8.2 Porter's Five Forces
9 Conclusion
Figure IBS-D Drug Market Size and CAGR 2013-2018 (Million USD)
Figure IBS-D Drug Market Size and CAGR 2013-2018 (Volume)
Figure IBS-D Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure IBS-D Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure IBS-C Drug Market Size and CAGR 2013-2018 (Million USD)
Figure IBS-C Drug Market Size and CAGR 2013-2018 (Volume)
Figure IBS-C Drug Market Forecast and CAGR 2019-2025 (Million USD)
Figure IBS-C Drug Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Women Market Size and CAGR 2013-2018 (Million USD)
Figure Women Market Size and CAGR 2013-2018 (Volume)
Figure Women Market Forecast and CAGR 2019-2025 (Million USD)
Figure Women Market Forecast and CAGR 2019-2025 (Volume)
Figure Men Market Size and CAGR 2013-2018 (Million USD)
Figure Men Market Size and CAGR 2013-2018 (Volume)
Figure Men Market Forecast and CAGR 2019-2025 (Million USD)
Figure Men Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2019-2025 (Volume)
Figure China Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Million USD)
Figure China Irritable Bowel Syndrome (IBS) Market Size and CAGR 2013-2017 (Volume)
Figure China Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Irritable Bowel Syndrome (IBS) Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Irritable Bowel Syndrome (IBS) SWOT List
Figure Irritable Bowel Syndrome (IBS) Porter's Five Forces